United States · Bill · HR
H.R. 3134 (118th)
Emergency Access to Insulin Act of 2023
Introduced
9 May 2023
Last action
17 December 2024 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Angie Craig, Dean Phillips
Subjects
Healthcare, Taxation
Source updated
5 December 2025
Summary
Emergency Access to Insulin Act of 2023 This bill reduces the marketing exclusivity period for biological drug products from 12 to 7 years and establishes policies and programs designed to increase access to prescription insulin. Specifically, the bill requires the Department of Health and Human Services (HHS) to award grants to states to create insulin card programs, which provide uninsured or underinsured individuals with insulin at no cost for specified time periods. Payments for insulin prescriptions made through the program must count toward an underinsured individual’s health plan deductible or other out-of-pocket expenses required under the plan. Further, HHS must collect annual fees from insulin manufacturers, based on each manufacturer’s market share, equal to the total estimated expenditures under the insulin grants program. Subject to certain exceptions, the bill also establishes an excise tax on insulin manufacturers when the price of an insulin product spikes. The tax amount is a specified percentage of the revenue a manufacturer received as a result of the price spike. The tax amount increases in tiers based on the percentage of the price spike for that product.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 May 2023
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
9 May 2023
Introduced
Introduced in House
Source: IntroReferral
9 May 2023
Introduced
Introduced in House
Source: IntroReferral
12 May 2023
Referred
Referred to the Subcommittee on Health.
Source: Committee
17 December 2024
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 9 May 2023 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 9 May 2023
Introduced in House (PDF)
Introduced in House · EN · 9 May 2023
Introduced in House
summary · EN · 9 May 2023
Sponsors
- Angie Craig · D · Sponsor
- Dean Phillips · D · Sponsor
- · hswm00 · Standing
- · hsif00 · Standing
Related records
- related to → Emergency Access to Insulin Act of 2023
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/3134
- Open data entity: https://api.congress.gov/v3/bill/118/hr/3134
- us · 118-hr-3134 · source updated 5 December 2025